Bill Text: IA SF2119 | 2019-2020 | 88th General Assembly | Enrolled

---

Bill Title: A bill for an act relating to controlled substances, including amending the controlled substance schedules, removing certain references to marijuana, making penalties applicable, and including effective date provisions. (Formerly SSB 3050.) Effective date: 06/01/2020.

Spectrum: Committee Bill

Status: (Passed) 2020-06-01 - Signed by Governor. S.J. 658. [SF2119 Detail]

Download: Iowa-2019-SF2119-Enrolled.html

---

Senate File 2119 - Enrolled
Senate File 2119
AN ACT
RELATING TO CONTROLLED SUBSTANCES, INCLUDING AMENDING THE
CONTROLLED SUBSTANCE SCHEDULES, REMOVING CERTAIN REFERENCES
TO MARIJUANA, MAKING PENALTIES APPLICABLE, AND INCLUDING
EFFECTIVE DATE PROVISIONS.
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
Section 1. Section 124.201A, Code 2020, is amended by
striking the section and inserting in lieu thereof the
following:
124.201A Cannabis-derived products —— rules.
1. If a cannabis-derived investigational product approved
as a prescription drug medication by the United States food

Senate File 2119, p. 2
and drug administration is added to the federal schedule
of controlled substances by the federal drug enforcement
administration and notice of the addition is given to the
board, the board shall similarly add the prescription drug
medication in the schedule of controlled substances under this
chapter.
2. If a cannabis-derived product approved as a
prescription drug medication by the United States food and
drug administration is eliminated from or revised in the
federal schedule of controlled substances by the federal drug
enforcement administration and notice of the elimination or
revision is given to the board, the board shall similarly
eliminate or revise the prescription drug medication in the
schedule of controlled substances under this chapter.
3. The board shall adopt rules pursuant to chapter 17A
to administer this section. The board may adopt rules on an
emergency basis as provided in section 17A.4, subsection 3, and
section 17A.5, subsection 2, to administer this section, and
the rules shall be effective immediately upon filing unless
a later date is specified in the rules. Any emergency rules
adopted in accordance with this section shall also be published
as a notice of intended action as provided in section 17A.4,
subsection 1.
4. Any cannabis-derived investigational product or
cannabis-derived product approved as a prescription drug
medication by the United States food and drug administration
shall not be considered marijuana or cannabimimetic agents,
both as defined in section 124.204, tetrahydrocannabinols
as used in section 124.204, subsection 4, paragraph “u” ,
unnumbered paragraph 1, or hemp as defined in section 204.2.
Sec. 2. Section 124.204, subsection 2, Code 2020, is amended
by adding the following new paragraph:
NEW PARAGRAPH . be. MT-45 (1-cyclohexyl-4-(1,2-
diphenylethyl)piperazine).
Sec. 3. Section 124.204, subsection 4, paragraph m, Code
2020, is amended to read as follows:
m. Marijuana , except as otherwise provided by rules of the
board for medicinal purposes .
Sec. 4. Section 124.204, subsection 4, paragraph u,

Senate File 2119, p. 3
unnumbered paragraph 1, Code 2020, is amended to read as
follows:
Tetrahydrocannabinols, except as otherwise provided
by rules of the board for medicinal purposes, meaning
tetrahydrocannabinols naturally contained in a plant of
the genus Cannabis (Cannabis plant) as well as synthetic
equivalents of the substances contained in the Cannabis plant,
or in the resinous extractives of such plant, and synthetic
substances, derivatives, and their isomers with similar
chemical structure and pharmacological activity to those
substances contained in the plant, such as the following:
Sec. 5. Section 124.204, subsection 6, paragraph i, Code
2020, is amended by adding the following new subparagraphs:
NEW SUBPARAGRAPH . (27) 1-(1,3-benzodioxol-5-yl)-2-
(ethylamino)-pentan-1-one. Other names: N-ethylpentylone or
ephylone.
NEW SUBPARAGRAPH . (28) N-Ethylhexedrone, its optical,
positional, and geometric isomers, salts and salts of isomers
(Other name: 2-(ethylamino)-1-phenylhexan-1-one).
NEW SUBPARAGRAPH . (29) alpha-Pyrrolidinohexanophenone, its
optical, positional, and geometric isomers, salts and salts of
isomers (Other names: α -PHP; alpha-pyrrolidinohexiophenone;
1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one).
NEW SUBPARAGRAPH . (30) 4-Methyl-alpha-
ethylaminopentiophenone, its optical, positional, and geometric
isomers, salts and salts of isomers (Other names: 4—MEAP;
2-(ethylamino)-1-(4-methylphenyl)pentan-1-one).
NEW SUBPARAGRAPH . (31) 4’-Methyl-alpha-
pyrrolidinohexiophenone, its optical, positional, and
geometric isomers, salts and salts of isomers (Other
names: MPHP; 4’-methyl-alpha-pyrrolidinohexanophenone;
1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one).
NEW SUBPARAGRAPH . (32) alpha-Pyrrolidinoheptaphenone,
its optical, positional, and geometic isomers,
salts and salts of isomers (Other names: PV8;
1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one).
NEW SUBPARAGRAPH . (33) 4’-Chloro-alpha-
pyrrolidinovalerophenone, its optical, positional, and
geometric isomers, salts and salts of isomers (Other names:

Senate File 2119, p. 4
4-chloro- α -PVP; 4’-chloro-alpha-pyrrolidinopentiophenone;
1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one).
Sec. 6. Section 124.204, subsection 7, Code 2020, is amended
by striking the subsection.
Sec. 7. Section 124.204, subsection 9, Code 2020, is amended
by adding the following new paragraphs:
NEW PARAGRAPH . af. N-(1-phenethylpiperidin-4-yl)-N-
phenylcyclopropanecarboxamide, its isomers, esters, ethers,
salts and salts of isomers, esters, and ethers. Other name:
cyclopropyl fentanyl.
NEW PARAGRAPH . ag. N-(1-phenethylpiperidin-4-yl)-N-
phenylpentanamide, its isomers, esters, ethers, salts and salts
of isomers, esters and ethers. Other name: valeryl fentanyl.
NEW PARAGRAPH . ah. N-(4-fluorophenyl)-N-(1-
phenethylpiperidin-4-yl)butyramide, its isomers, esters,
ethers, salts and salts of isomers, esters, and ethers. Other
name: para-fluorobutyryl fentanyl.
NEW PARAGRAPH . ai. N-(4-methoxyphenyl)-N-
(1-phenethylpiperidin-4-yl)butryamide, its isomers, esters,
ethers, salts and salts of isomers, esters, and ethers. Other
name: para-methyoxybutyryl fentanyl.
NEW PARAGRAPH . aj. N-(4-chlorophenyl)-N-(1-
phenethylpiperidin-4-yl)isobutryramide, its isomers, esters,
ethers, salts and salts of isomers, esters, and ethers. Other
name: para-chloroisobutyryl fentanyl.
NEW PARAGRAPH . ak. N-(1-phenethylpiperidin-4-yl)-
N-phenylisobutyramide, its isomers, esters, ethers, salts and
salts of isomers, esters, and ethers. Other name: isobutyryl
fentanyl.
NEW PARAGRAPH . al. N-(1-phenethylpiperidin-4-yl)-
N-phenylcyclopentanecarboxamide, its isomers, esters, ethers,
salts and salts of isomers, esters, and ethers. Other name:
cyclopentyl fentanyl.
NEW PARAGRAPH . am. N-(2-fluorophenyl)-2-methoxy-N-
(1-phenethylpiperidin-4-yl)acetamide, its isomers, esters,
ethers, salts and salts of isomers, esters, and ethers. Other
name: ocfentanil.
NEW PARAGRAPH . an. Fentanyl-related substances, their
isomers, esters, ethers, salts and salts of isomers, esters

Senate File 2119, p. 5
and ethers. “Fentanyl-related substance” means any substance
not otherwise listed under this schedule or another schedule,
and for which no exemption or approval is in effect under
section 505 of the federal Food, Drug, and Cosmetic Act that
is structurally related to fentanyl by one or more of the
following modifications:
(1) Replacement of the phenyl portion of the phenethyl group
by any monocycle, whether or not further substituted in or on
the monocycle.
(2) Substitution in or on the phenethyl group with alkyl,
alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino, or nitro
groups.
(3) Substitution in or on the piperidine ring with alkyl,
alkenyl, alkoxyl, ester, ether, hydroxyl, halo, haloalkyl,
amino, or nitro groups.
(4) Replacement of the aniline ring with any aromatic
monocycle whether or not further substituted in or on the
aromatic monocycle.
(5) Replacement of the N -propionyl group by another acyl
group.
NEW PARAGRAPH . ao. Naphthalen-1-yl 1-(5-fluoropentyl)-
1 H -indole-3-carboxylate. Other names: NM2201 or CBL2201.
NEW PARAGRAPH
. ap. N -(1-amino-3-methyl-1-oxobutan-
2-yl)-1-(5-fluoropentyl)-1 H -indazole-3-carboxamide. Other
name: 5F-AB-PINACA.
NEW PARAGRAPH . aq. 1-(4-cyanobutyl)- N -(2-phenylpropan-
2-yl)-1 H -indazole-3-carboxamide. Other names:
4-CN-CUMYL-BUTINACA, 4-cyano-CUMYL-BUTINACA, 4-CN-CUMYL
BINACA, CUMYL-4CN-BINACA, or SGT-78.
NEW PARAGRAPH . ar. Methyl 2-(1-(cyclohexylmethyl)-1 H -
indole-3-carboxamido)-3-methylbutanoate. Other names:
MMB-CHMICA or AMB-CHMICA.
NEW PARAGRAPH . as. 1-(5-fluoropentyl)- N -(2-
phenylpropan-2-yl)-1 H -pyrrolo[2,3-b]pyridine-3-carboxamide.
Other name: 5F-CUMYL-P7AICA.
NEW PARAGRAPH . at. Ethyl 2-(1-(5-fluoropentyl)-1H-
indazole-3-carboxamido)-3,3-dimethylbutanoate, its optical,
positional, and geometric isomers, salts and salts of isomers
(other name: 5F-EDMB-PINACA).

Senate File 2119, p. 6
NEW PARAGRAPH . au. Methyl 2-(1-(5-fluoropentyl)-1H-indole-
3-carboxamido)-3,3-dimethylbutanoate, its optical, positional,
and geometric isomers, salts and salts of isomers (other name:
5F-MDMB-PICA).
NEW PARAGRAPH . av. N-(adamantan-1-yl)-1-(4-fluorobenzyl)-
1H-indazole-3-carboxamide, its optical, positional, and
geometric isomers, salts and salts of isomers (other names:
FUB-AKB48, FUB-APINACA, AKB48 N-(4-FLUOROBENZYL)).
NEW PARAGRAPH . aw. 1-(5-fluoropentyl)-N-(2-
phenylpropan-2-yl)-1H-indazole-3-carboxamide, its optical,
positional, and geometric isomers, salts and salts of isomers
(other names: 5F-CUMYL-PINACA, SGT-25).
NEW PARAGRAPH . ax. (1-(4-fluorobenzyl)-1H-
indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone, its
optical, positional, and geometric isomers, salts and salts of
isomers (other name: FUB-144).
Sec. 8. Section 124.206, subsection 7, paragraph a, Code
2020, is amended by striking the paragraph.
Sec. 9. Section 124.208, subsection 3, paragraph c, Code
2020, is amended to read as follows:
c. Any substance which contains any quantity of a derivative
of barbituric acid or any salt thereof including but not
limited to Fioricet .
Sec. 10. Section 124.210, subsection 3, Code 2020, is
amended by adding the following new paragraph:
NEW PARAGRAPH . bd. Brexanolone.
Sec. 11. Section 124.210, subsection 6, Code 2020, is
amended by adding the following new paragraph:
NEW PARAGRAPH . m. Solriamfetol (2-amino-3-phenylpropyl
carbamate; benzenepropanol, beta-amino-, carbamate (ester).
Sec. 12. Section 124.212, Code 2020, is amended by adding
the following new subsection:
NEW SUBSECTION . 6. Approved cannabidiol drugs. A
drug product in finished dosage formulation that
has been approved by the United States food and
drug administration that contains cannabidiol
(2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-
pentyl-1,3-benzenediol) derived from cannabis and no more than
0.1 percent (w/w) residual tetrahydrocannabinols.

Senate File 2119, p. 7
Sec. 13. EFFECTIVE DATE. This Act, being deemed of
immediate importance, takes effect upon enactment.
______________________________ ______________________________
CHARLES SCHNEIDER PAT GRASSLEY
President of the Senate Speaker of the House
I hereby certify that this bill originated in the Senate and
is known as Senate File 2119, Eighty-eighth General Assembly.
______________________________
W. CHARLES SMITHSON
Secretary of the Senate
Approved _______________, 2020 ______________________________
KIM REYNOLDS
Governor